Literature DB >> 22499242

Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells.

Dick Pluim1, Lot A Devriese, Jos H Beijnen, Jan H M Schellens.   

Abstract

A simple, selective, and sensitive multiparameter fluorescence activated cell sorting method utilizing density gradient centrifugation and magnetic antibody cell sorting was developed and validated for the determination of phosphorylated extracellular-signal-regulated kinase (pERK) and DNA in circulating tumor cells (CTCs). Cell preparation tubes (CPT) were used for peripheral blood collection and density gradient centrifugation, followed by phosphorylation of ERK with epidermal growth factor (EGF). After fixation with formaldehyde and methanol, magnetic anti epithelial cell adhesion molecule (EpCAM) micro-beads were used for the selective isolation of CTCs from the background, consisting of peripheral blood mononuclear cells and platelets. Subsequently, samples were stained with Hoechst 33342, and fluorescent antibodies against EpCAM, CD45, and pERK. Flow cytometry was used for identification and enumeration of CTCs and determination of their pERK and DNA content. The validation parameters included specificity, recovery, linearity, precision, sensitivity, and stability. The lower limit of quantification was two CTCs per 8 ml peripheral blood. Samples were stable for 4 months in storage at -80°C. The applicability of the method was demonstrated by successful enumeration of CTCs, and the determination of DNA, and pERK before and after stimulation with EGF in 8 ml peripheral blood samples from patients with metastatic cancer.
Copyright © 2012 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22499242     DOI: 10.1002/cyto.a.22049

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  9 in total

1.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 2.  Circulating tumor cell technologies.

Authors:  Meghaan M Ferreira; Vishnu C Ramani; Stefanie S Jeffrey
Journal:  Mol Oncol       Date:  2016-01-28       Impact factor: 6.603

3.  EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.

Authors:  Bojana Milojkovic Kerklaan; Dick Pluim; Mijke Bol; Ingrid Hofland; Johan Westerga; Harm van Tinteren; Jos H Beijnen; Willem Boogerd; Jan H M Schellens; Dieta Brandsma
Journal:  Neuro Oncol       Date:  2015-11-12       Impact factor: 12.300

Review 4.  Profiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?

Authors:  Marcin Braun; Aleksandra Markiewicz; Radzisław Kordek; Rafał Sądej; Hanna Romańska
Journal:  Cancers (Basel)       Date:  2019-01-25       Impact factor: 6.639

Review 5.  Technologies for circulating tumor cell separation from whole blood.

Authors:  Petra Bankó; Sun Young Lee; Viola Nagygyörgy; Miklós Zrínyi; Chang Hoon Chae; Dong Hyu Cho; András Telekes
Journal:  J Hematol Oncol       Date:  2019-05-14       Impact factor: 17.388

6.  Fast and efficient microfluidic cell filter for isolation of circulating tumor cells from unprocessed whole blood of colorectal cancer patients.

Authors:  Silvina Ribeiro-Samy; Marta I Oliveira; Thais Pereira-Veiga; Laura Muinelo-Romay; Sandra Carvalho; João Gaspar; Paulo P Freitas; Rafael López-López; Clotilde Costa; Lorena Diéguez
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

7.  Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays.

Authors:  Joanna Budna-Tukan; Monika Świerczewska; Martine Mazel; Wojciech A Cieślikowski; Agnieszka Ida; Agnieszka Jankowiak; Andrzej Antczak; Michał Nowicki; Klaus Pantel; David Azria; Maciej Zabel; Catherine Alix-Panabières
Journal:  Cancers (Basel)       Date:  2019-06-10       Impact factor: 6.639

Review 8.  Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology.

Authors:  Patrick C Bailey; Stuart S Martin
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

Review 9.  Circulating Tumor Cells from Enumeration to Analysis: Current Challenges and Future Opportunities.

Authors:  Yu-Ping Yang; Teresa M Giret; Richard J Cote
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.